Send an RFQ for Beckman Coulter 361302, Bases for MicroPlus Carriers (with pads). Iright supports global sourcing and international shipment for life science and laboratory products.
| Verified Reactivity | Human |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Immunogen | Recombinant human IL-34 |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography. |
| Concentration | 0.5 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C. |
| Application | ELISA Capture - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by ELISA assay. For ELISA capture applications, a concentration range of 2-8 µg/mL is recommended. To obtain a linear standard curve, serial dilutions of human IL-34 recombinant protein ranging from 5000 to 78 pg/mL are recommended for each ELISA plate. It is recommended that the reagent be titrated for optimal performance for each application. |
| Application Notes | ELISA Capture: The purified E0320E7 antibody is useful as the capture antibody in a sandwich ELISA assay, when used in conjunction with the biotinylated E033B8 antibody (Cat. No. 361401) as the detection antibody and recombinant human IL-34 (Cat. No. 577909) as the standard. Note: For testing human IL-34 in serum, plasma or cell culture supernatant, LEGEND MAX™ Human IL-34 ELISA Kit with Pre-coated Plates (Cat. No. 439607 & 439608) are specially developed and recommended. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Product Citations | Han N, et al. 2021. STAR Protocols. 2(2):100460. PubMed |
|---|
| RRID | AB_2563032 (BioLegend Cat. No. 361301) |
|---|
| Structure | Secreted glycoprotein, homodimer |
|---|
| Distribution | IL-34 mRNA is expressed in many different tissues including: spleen, heart, brain, lung, liver, kidney, thymus, testes, ovary, small intestine, prostate, and colon |
|---|
| Function | IL-34 increases monocyte viability, induces macrophage proliferation, and synergizes with other cytokines to generate macrophages and osteoclasts from cultured progenitors. IL-34 promotes the formation of the colony forming unit-macrophage (CFU-M) in human bone marrow culture. IL-34 supports RANKL-induced osteoclastogenesis by promoting the adhesion and proliferation of osteoclast progenitors. Human IL-34 promotes osteoclast differentiation from peripheral blood mononucleated cells. In addition, systematic administration of IL-34 to mouse increases the number of CD11b+ cells and reduces bone mass. IL-1ß and TNF-α induce the expression of interleukin-34 mRNA in osteoblasts. IL-34 is also induced in macrophages infected with equine infectious anemia virus (EIAV). |
|---|
| Interaction | Macrophages, monocytes, myeloid cells |
|---|
| Ligand/Receptor | CSF-1R |
|---|
| Biology Area | Cell Biology, Immunology |
|---|
| Molecular Family | Cytokines/Chemokines |
|---|
| Antigen References | 1. Clanchy FI, et al. 2006. J. Leuko. Biol. 79:757. 2. Lin H, et al. 2008. Science 320:807. 3. Chihara T, et al. 2010. Cell. Death Differ. 17:1917. 4. Wei S, et al. 2010. J. Leuko. Biol. 88:495. 5. Eda H, et al. 2011. Rheumatol. Int. 31:1525. |
|---|
| Gene ID | 146433 |
|---|
| UniProt | View information about IL-34 on UniProt.org |
|---|
| Clone | E0320E7 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Interleukin 34, C16orf77 |
|---|
| Isotype | Mouse IgG2b, λ |
|---|